DelphX Capital Markets Inc. (TSXV: DELX | OTCQB: DPXCF), a structured products developer based in Toronto, has announced it will adopt semi-annual financial reporting under the Canadian Securities Administrators' semi-annual reporting pilot program. The company will not file an interim financial report or related MD&A for the three and nine months ended September 30, 2026, marking the first interim period under the exemption. The move is intended to reduce reporting costs and redirect management resources toward developing and distributing its structured products offering.

Key Points

  • DelphX Capital Markets Inc. (TSXV: DELX | OTCQB: DPXCF) is a Toronto-based structured products and financial technology company
  • The company is adopting semi-annual financial reporting under the CSA's venture issuer pilot program
  • Next required periodic filings are audited annual financial statements and annual MD&A for the year ending December 31, 2026, due on or before April 30, 2027
  • Investors should watch for the company's continued timely disclosure obligations, including material change reports and news releases

DelphX Opts Into CSA Semi-Annual Reporting Exemption

DelphX announced the change pursuant to Coordinated Blanket Order 51-933, which permits certain venture issuers to reduce their interim reporting obligations. Under this exemption, the company will no longer file quarterly interim financial reports or accompanying MD&A documents. Instead, it will file an interim financial report and related MD&A covering the six-month period of each financial year, in addition to its audited annual financial statements. The company stated it will continue to meet all timely disclosure obligations, including issuing news releases and filing material change reports as required.

Resource Reallocation Toward Structured Products Development

The company cited cost reduction and management efficiency as the primary rationale for the reporting change. By reducing the administrative burden of quarterly filings, DelphX stated it intends to direct those resources toward the development and distribution of its structured product offerings. DelphX operates through its special purpose vehicle Quantem LLC, which enables broker-dealers to offer collateralized put options and collateralized reference notes to qualified institutional investors. The release states that all such products are fully collateralized and held in custody by US Bank.

Annual Filing Deadline and Ongoing Disclosure Obligations

The company confirmed that its next required periodic filings will be the audited annual financial statements and annual MD&A for the fiscal year ending December 31, 2026, which must be filed on or before April 30, 2027. DelphX also clarified that its commitment to timely disclosure remains unchanged despite the reduced interim reporting schedule, with the company maintaining obligations to issue news releases and file material change reports when circumstances require. Investors may be watching to assess how the resource reallocation affects product development milestones over the coming months.